Welcome
Welcome to the official web site for the upcoming
conference on HHV-6 & 7, organized by the HHV-6 Foundation.
Dr. Robert Gallo of the Institute of Human Virology and Dr. Phillip
Pellett of the Cleveland Clinic will serve as Co- chairs of the
conference. Dr. Dharam Ablashi, co-discoverer of the virus and
Scientific Director of the HHV-6 Foundation will serve as Co- Chairs
of the Program Committee with Steve Jacobson of the NINDS and
Phillip Pellett of the Cleveland Clinic. The HHV-6 Foundation
is a non-profit entity formed to foster basic and clinical
research into HHV-6 and its disease associations.
Special workshops on HHV-6
in
Epilepsy, Encephalitis & MS
There is fascinating new evidence that HHV-6 plays a role in a
number of neurological conditions. The entire day of June 22nd
will be devoted to HHV-6 in various CNS disorders.
 Satellite session: Viruses in CFS
Due to new research suggesting the possibility of a viral etiology
in a subset of CFS patients, we are sponsoring a special satellite
session June 22nd-23rd titled “Viruses in CFS.”
Please see the special Satellite Workshop section on this site
for more information.
|
|
Conference Topics
The HHV-6 Conference will cover the following topics:
- Overviews on HHV-6 & 7
- Epidemiology
- Chromosomally integrated HHV-6
- Molecular
Biology
- Cell Biology
- Molecular and Serological Assays
- Reactivation
in Transplant Patients
- HHV-6
in CNS Dysfunction/CFS
- HHV-6 in Myocarditis
- HHV-6 Immunosuppression & AIDS
- HHV-6 & 7 in skin
disorders & DIHS
- Antivirals & Immunomodulatory
Treatments
- HHV-6
in Multiple Sclerosis
- HHV-6 in Malignancy
- HHV-6 in Encephalitis
- HHV-6 in Epilepsy, Status
Epilepticus, and Seizures
Events During The Conference
We have several extracurricular events lined up during the conference.
Please check back in March to find out more.
Baltimore
You will enjoy visiting beautiful Baltimore in the early
summer when the weather is ideal.
We have been able to negotiate
a very favorable room rate at the Hyatt Baltimore Inner Harbor.
|
